A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19 syndrome and registered on WHO International Clinical Trials Platform.

ABSTRACT:

Background

Post-acute COVID-19 syndrome (PACS) is a well-recognized, complex, systemic disease which is associated with substantial morbidity. There is a paucity of established interventions for the treatment of patients with this syndrome.

Objectives

To systematically review registered trials currently investigating therapeutic modalities for PACS.

Data sources

A search was conducted up to the 16 September, 2022, using the COVID-19 section of the WHO Internal Clinical Trials Registry Platform.

Study eligibility criteria, participants, and interventions

Interventional clinical trials of any sample size examining any therapeutic modality targeting persistent symptoms among individuals after diagnosis with COVID-19.

Methods

Data on trial characteristics an

SUBMITTER: Ashraf N 

PROVIDER: S-EPMC9837206 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature